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Abstract
Background: Bacterial diarrhoeal disease is among the most common causes of mortality and morbidity in
children 0–59 months at the University Teaching Hospital in Lusaka, Zambia. However, most cases are treated
empirically without the knowledge of aetiological agents or antimicrobial susceptibility patterns. The aim of this
study was, therefore, to identify bacterial causes of diarrhoea and determine their antimicrobial susceptibility
patterns in stool specimens obtained from the children at the hospital.
Methods: This hospital-based cross-sectional study involved children aged 0–59 months presenting with diarrhoea
at paediatrics wards at the University Teaching Hospital in Lusaka, Zambia, from January to May 2016. Stool samples
were cultured on standard media for enteropathogenic bacteria, and identified further by biochemical tests.
Multiplex polymerase chain reaction was used for characterization of diarrhoeagenic Escherichia coli strains.
Antimicrobial susceptibility testing was performed on antibiotics that are commonly prescribed at the hospital
using the Kirby-Bauer disc diffusion method, which was performed using the Clinical Laboratory Standards
International guidelines.
Results: Of the 271 stool samples analysed Vibrio cholerae 01 subtype and Ogawa serotype was the most
commonly detected pathogen (40.8%), followed by Salmonella species (25.5%), diarrhoeagenic Escherichia coli (18%)
, Shigella species (14.4%) and Campylobacter species (3.5%). The majority of the bacterial pathogens were resistant
to two or more drugs tested, with ampicillin and co-trimoxazole being the most ineffective drugs. All
diarrhoeagenic Escherichia coli isolates were extended spectrum β-lactamase producers.
Conclusion: Five different groups of bacterial pathogens were isolated from the stool specimens, and the majority
of these organisms were multidrug resistant. These data calls for urgent revision of the current empiric treatment of
diarrhoea in children using ampicillin and co-trimoxazole, and emphasizes the need for continuous antimicrobial
surveillance as well as the implementation of prevention programmes for childhood diarrhoea.
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Background
Infectious diarrhoea is a significant cause of illness and
death among children under 5 years of age in low-
resource countries. It accounts for 9% of all deaths
globally in this age group, and ranks only second to pneu-
monia [1]. The majority of these cases are associated with
the first two years of life, with peak ages being between 6
and 11 months [1, 2]. Although mortality associated with
diarrhoea has been decreasing since 2000, mainly due to
the implementation of effective control programmes and
improved socioeconomic status, it still remains an import-
ant reason for hospital admissions and deaths among the
children [3]. South-East Asia and sub-Saharan Africa bear
the highest burden of the disease [1, 4].
Interventions that target the main causes of diarrhoea
should focus on the most susceptible children, and this
should further accelerate decline of diarrhoeal cases.
Guiding these efforts requires identification of aetiological
agents and understanding the risk factors associated with
diarrhoea. Most cases of diarrhoea are associated with
consumption of contaminated water and food, and poor
sanitation, which create an ideal environment for diar-
rhoeal pathogens to be easily transmitted [2, 5]. Several
pathogens have been implicated as important causes of
diarrhoea, and these include a variety of bacteria, parasites
and viruses [4, 6, 7].
Although the most effective treatment for acute diar-
rhoea is fluid and electrolyte replacement, antibacterial
agents are often indicated in dysentery, typhoid fever
and severe cholera [3, 8]. However, in recent years there
has been growing concern of antimicrobial resistance in
bacterial pathogens associated with diarrhoea [9–11].
Thus, there is an urgent need for global surveillance of
antimicrobial resistance as this is important in the man-
agement of children with diarrhoea [12].
Despite diarrhoea in children being acknowledged as a
serious public health problem in Zambia, there is a pau-
city of data on infectious diarrhoeal agents, especially
bacterial pathogens and their antimicrobial susceptibility
patterns due to the few studies that have been conducted
in the country [13–15]. Since aetiological agents and
drug resistance patterns vary greatly across countries, re-
gions and communities over time, current local know-
ledge of these patterns is essential to inform treatment,
prevention and control programmes. Therefore, the aim
of this study was to identify bacterial pathogens in stool
samples obtained from children aged 0–59 months ad-
mitted with diarrhea to the University Teaching Hospital
(UTH) in Lusaka, Zambia.
Methods
Setting
The study was conducted at the University Teaching
Hospital (UTH), a tertiary referral and teaching hospital
in Lusaka with a bed capacity of approximately 2000,
and is also the reference centre for all microbiology
diagnostic work in Zambia.
Type of study
This was a cross sectional study. Stool samples were col-
lected from children aged 0–59 months with diarrhoea
who attended the UTH from December 2015 to April
2016. Samples were submitted to the microbiology la-
boratory to determine the presence of bacterial entero-
pathogens and their antimicrobial susceptibility patterns.
Isolation and identification of bacterial enteropathogens
Stool samples were inoculated onto MacConkey, Deoxy-
cholate Citrate Agar (DCA) and Xylose Lysine Deoxycho-
late (XLD) agar plates (Mast Diagnostics Ltd, Merseyside,
UK). Samples from suspected cases of cholera were first
inoculated into alkaline peptone water and subcultured
onto Thiosulphate Citrate Bile Salt (TCBS) (Mast Diag-
nostics Ltd, Merseyside, UK). All cultures were incubated
at 35–37 °C for 12–18 h except for the modified
Charcoal-Cefoperazone Deoxycholate Agar (mCCDA)
plates (Himedia, Mumbai, India), which were incubated at
42 °C for 72 h in a candle jar sealed with parafilm (Paraf-
ilm M, Pechiney Plastic Packaging, Chicago, USA). C.
jejuni ATCC 33291 strain was used as a positive control.
Figure 1 show the approach used for the identification
process for the bacterial enteropathogens.
For the identification of diarrhoeagenic Escherichia
coli (DEC), DNA from the isolates was extracted on
the easyMag instrument (bioMérieux, Marcy I’Etoile,
France) according to the manufacturer’s instructions
using the “on-board lysis” protocol. DNA was eluted
in a final volume of 110 μl. All isolates identified as
E. coli were screened further for virulence genes by
multiplex real-time Polymerase Chain Reaction (PCR)
targeting specific genes that are associated with six
different pathotypes of DEC: enteropathogenic E. coli
(ETEC), enteroinvasive E. coli (EIEC), enteropatho-
genic E. coli (EPEC), enteroaggregative E. coli (EAEC),
Shiga toxin-producing E. coli (STEC and diffusely ad-
herent E. coli (DAEC). The minimum criteria for de-
termining diarrhoeagenic E. coli were defined as the
presence of stIa/stIb and lt for ETEC, presence of
ipaH for EIEC, presence of eaeA for EPEC, presence
of aggR for EAEC, stx 1 and stx 2 for STEC and
daaD for DAEC [16]. The PCR assay was carried out
as previously described [16]. E. coli DH5α, which
lacks all the diarrhoeagenic genes, was used as a
negative control. The PCR was performed on an
Applied Biosystems 7500 Real-Time PCR cycler (Life
Technologies, California, USA) (Fig. 1).
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Antimicrobial susceptibility
This was performed by the Kirby-Bauer disc diffusion
method using the CLSI guidelines [17] on Müeller-Hin-
ton agar plates (Mast Diagnostics Ltd, Merseyside, UK)
(Table 1). Isolates of E. coli were also screened for Ex-
tended Spectrum β-Lactamases (ESBL) production by
testing them against cefpodoxime (10 μg), ceftazidime
(30 μg), and cefotaxime (30 μg) (Mast Diagnostics Ltd,
Merseyside, UK) as indicator cephalosporins [18]. Pro-
duction of ESBLs was confirmed phenotypically by using
the combination discs on Müeller-Hinton agar plates
(Mast Diagnostics Ltd, Merseyside, UK): cefotaxime/cla-
vulanic acid, cefpodoxime/clavulanic acid and ceftazi-
dime/clavulanic acid (Mast Diagnostics Ltd, Merseyside,
UK). After incubation for 18–24 h at 37 °C, the zones of
inhibition of the indicator cephalosporin and cephalo-
sporin/clavulanic acid were measured using Vernier cal-
lipers and compared. Confirmation of ESBL production
was indicated by the zone size of the cephalosporin/cla-
vulanic acid being greater than the indicator cephalo-
sporin (i.e., ≥5 mm). E. coli ATCC 25922 and S. aureus
ATCC 25923 were used as quality control strains for
susceptibility testing.
Data analysis
Data analysis was performed with GraphPad Prism Soft-
ware Version 5.0 for Windows (GraphPad Software, San
Diego, California, USA) and EpiInfo Version 7.1.5 Soft-
ware (CDC, Atlanta, USA). Descriptive data analysis was
utilized to determine the range of enteropathogens and
distribution of study covariates.
Results
Isolation and identification of bacterial enteropathogens
Of the 271 children enrolled, 54.6% of them were boys,
while the rest were girls (45.4%). Most of the children
were less than 24 months (61.3%), followed by those aged
between 48 and 59 months (15.5%), 24 to 35 months
(12.6%) and 36 to 47 months (10.7%) (Table 2).
Culture results showed that 31.4% of the stool samples
analysed were positive for five different bacterial entero-
pathogens: Vibrio cholerae (40.8%), Salmonella species
(25.5%), DEC (18%), Shigella species (14.4%) and Cam-
pylobacter species (3.5%) (Table 3). All the V. cholerae
isolates detected were of the 01 subtype and Ogawa
serotype. Amongst the Salmonella species, 52.4%) were
S. Typhi, 19.1% were S. Paratyphi B and 28.6% were
Non-Typhoidal Salmonella (NTS). Of the DEC detected,
the most frequent was ETEC (40%), followed by EIEC
(26.7%), EAEC (20%), and EPEC (13.3%). No STEC or
DEAC strains were detected. Of the 12 Shigella isolates,
50% were Shigella flexneri, 33.3% were Shigella dysenter-
iae and 16.7% were Shigella boydii. Campylobacter jejuni
comprised only 3.5% of the total number of isolates
(Table 3).
Vibrio cholerae and Salmonella species were most
commonly recovered from children aged between 12
and 23 months. The most prevalent pathogen, V.
Fig. 1 Flow chart showing the isolation and identification of bacterial enteropathogens
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cholerae, was detected mainly in children older than
12 months. DEC mainly affected children less than
12 months, while Shigella mainly affected children older
than 36 months.
Antimicrobial susceptibility patterns
All V. cholerae isolates exhibited 100% resistance to co-
trimoxazole, nalidixic acid and nurafurantoin. The
isolates showed low level of resistance to erythromycin
(32.4%), ciprofloxacin (26.5%), norfloxacin (20.5%) and
chloramphenicol (8.8%). All the isolates were 100% sus-
ceptible azithromycin, ampicillin, cefotaxime and genta-
micin, while the strains were 94.1% sensitive and 5.9%
intermediate to tetracycline.
We also attempted to find antimicrobial resistance pat-
terns of the bacterial enteropathogens. Multidrug resistance
Table 2 Number of diarrhoeal cases identified, subdivided according to child age and gender
Characteristic n (%) Bacterial enteropathogens
V. cholerae Salmonella E. coli Shigella Campylobacter
n (%) n (%) n (%) n (%) n (%)
Gender
Male 48 (56.5) 23 (27.1) 12 (14.1) 6 (7.1) 6 (7.1) 1 (1.2)
Female 37 (43.5) 11 (12.9) 9 (10.6) 9 (10.6) 6 (7.1) 2 (2.3)
Age group (months)
< 12 14 (16.5 2 (5.9) 4 (19.0) 6 (40.0) 2 (16.7) 0 (0.0)
12–23 28 (32.9) 13 (38.2) 10 (47.6) 3 (20.0) 1 (8.3) 1 (33.3)
24–35 11 912.9) 5 (14.7) 4 (19.0) 1 (6.7) 1 (8.3) 0 (0.0)
36–47 13 (15.3) 7 (20.6) 1 (4.8) 2 (13.3) 3 (25.0) 0 (0.0)
48–59 19 (22.4) 7 (20.6) 2 (9.5) 3 (20.0) 5 (41.7) 2 (66.7)
Table 1 Antibiotic used in this study and their concentrations
Antibiotic Abbrev Conc (μg) Bacterial pathogen
V. cholerae Salmonella E. coli Shigella Campylobacter
Amoxillin/clavulanic acid AMC 20 N Y N Y N
Ampicilin AMP 10 Y Y Y Y Y
Azithromycin AZM 15 Y Y N Y N
Cefdoxime CPD 10 N N Y N N
Cefotaxime CTX 30 Y Y Y Y N
Ceftazidime CAZ 30 N N Y N N
Chloramphenicol CHL 30 Y Y Y Y Y
Ciprofloxacin CIP 5 Y Y Y N Y
Clindamycin CLI 10 N N N N Y
Colistin CST 25 N Y N Y N
Co-trimoxazole CMX 25 Y Y Y Y Y
Doxycycline DOX 30 N N N N Y
Erythromycin ERY 15 Y Y N N Y
Gentamicin GEN 10 Y Y N Y Y
Nalidixic acid NAL 30 Y Y Y Y Y
Neomycin NEO 10 N Y N Y N
Nitrofurantoin NIT 30 Y N N N N
Norfloxacin NOR 10 Y Y N N Y
Spectinomycin SPT 25 N Y N Y N
Streptomycin STR 10 N Y Y Y N
Tetracycline TET 30 Y Y Y Y Y
Abbrev abbreviations, Y yes, N no
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(MDR) was defined as resistance to three or more drugs.
The majority of the V. cholera (97%) were MDR with 9
different patterns. The most common pattern was
ciprofloxacin-cotrimoxazole-erythromycin-nalidixic acid
(11.8%), followed by ciprofloxacin-cotrimoxazole-nalidixic
acid-norfloxacin (8.8%) and cotrimoxazole-erythromycin-
nalidixic acid (5.9%) (Table 4).
S. Typhi species displayed 100% resistance to ampi-
cillin, co-trimoxazole and streptomycin, 72.7% to
chloramphenicol, 18.2% to azithromycin and 9.1% to
ciprofloxacin. The isolates isolates had four different MDR
patterns, the commonest being ampicillin-chloramphenicol-




(9.1%). However, these isolates were all susceptible to nali-
dixic acid, amoxycylin-clavulanic acid, tetracycline, spec-
tinomycin, gentamicin, cefotaxime, neomycin and colistin.
S. Paratyphi B isolates were 100% resistant to ampicillin,
co-trimoxazole and streptomycin, chloramphenicol and
75% resistant to spectinomycin. Its MDR patterns
were ampicillin-chloramphenicol-cotrimoxazole-spec-
tinomycin-streptomycin (75%) and ampicillin-
chloramphenicol-cotrimoxazole-streptomycin (25%). This
group of Salmonella isolates were susceptible to azithro-
mycin, ciprofloxacin, nalidixic acid, amoxycylin-clavulanic
acid, gentamicin, cefotaxime, neomycin and colistin. The
NTS isolates showed the following resistance patterns:
100% to co-trimoxazole, 88.3% to ampicillin, 66.7% to
streptomycin, 50% to chloramphenicol, 33.3% to spectino-
mycin, and 16.7% to both colistin and tetracycline. The
group had six different patterns each exhibiting 16.7%
(Table 5). These isolates were also susceptible to the fol-
lowing antibiotics: to azithromycin, ciprofloxacin, nalidixic
acid, amoxycylin-clavulanic acid, gentamicin, cefotaxime
and neomycin.
DEC generally exhibited high rates of resistance to
most antibiotics tested. ETEC strains were more resist-
ant to co-trimoxazole (100%), followed by ampicillin and
cefotaxime (66.7%), ceftazidime (66.7%), cefpodoxime
(66.7%), tetracycline (both 50%), streptomycin (33.7),
chloramphenicol and nalidixic acid (both 16.4%). The
four types of DEC isolated showed 100% resistance to
co-trimoxazole and each type was 50% resistant to tetra-
cycline. The most resistant strains belonged to the EPEC
group. The stains displayed the following MDR patterns:
ETEC, six; EIEC, four; EAEC, three; and EPEC, two
(Table 6).
After analysing all the 15 isolates of DEC for
ESBL production, 66.7% (10/15) were found to be
resistant to cefotaxime, ceftazidime and cefpodox-
ime, suggesting that they were potential producers
of ESBL. Further analysis of the isolates with a
confirmatory test (combination discs: cefotaxime-
clavulanic acid, ceftazidime clavulanic acid and cef-
podoxime clavulanic acid) showed that all of them
were ESBL-producers.
Among the Shigella species, S. flexneri was resistant to
ampicillin and co-trimoxazole (both 100%), followed by chlor-
amphenicol and streptomycin (both 83.8%), amoxicillin-
clavulanic acid, and tetracycline (both 16.5%). S. dysenteriae
displayed 100% resistance to both ampicillin and co-
trimoxazole (75%), to chloramphenicol (25%) and 25%
to tetracycline. S. bodii was 100% resistant to ampicil-
lin, co-trimoxazole and chloramphenicol. Their MDR
patterns were as follows: flexneri, 4, the commonest being
ampicillin-chloramphenicol-cotrimoxazole-streptomycin
(50%); S. dysenteriae, 2, with ampicillin-chloramphenicol-
cotrimoxazole-streptomycin being the commonest (75%); and
Table 3 Distribution of bacterial enteropathogens isolated stool
specimens
Bacterial enteropathogen n (%)
Vibrio cholerae 01 (Ogawa) 34 (40.8)
Salmonella species 21 (25.2)
Salmonella Typhi 11 (52.4)
Salmonella Paratyphi B 4 (19.1)
Other Salmonellae 6 (28.6)





Shigella species 12 (14.4)
Shigella flexneri 6 (50.0)
Shigella dysenteriae 4 (33.3)
Shigella boydii 2 (16.7)
Campylobacter jejuni 3 (3.5)
DEC diarrhoeagenic E. coli, ETEC enterotoxigenic E. coli, EIEC enteroinvasive E.
coli, EAEC enteroaggregative E. coli, enteropathogenic E. coli, n number
Table 4 Antimicrobial resistance pattern of V. cholerae
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both S. boydii displayed only two different patterns,
ampicillin-chloramphenicol-cotrimoxazole (100%) (Table 7).
The three Campylobacter jejuni species isolated were
only resistant to co-trimoxazole (100%), ampicillin
(33.3%) and tetracycline (33.3%).
Discussion
Five different bacterial enteropathogens were isolated
from some of the stool specimens, and these included V.
cholerae 01 Ogawa serotype, Salmonella species, Shigella
species, DEC and Campylobacter species. V. cholerae was
the most predominant pathogen due to a cholera outbreak
during the study period. Our results were in agreement
with previous studies done in Lusaka [19, 20]. However,
none of these studies focused on cholera in children.
Salmonella species was the second most prevalent
genera (25.5%); and the majority of the species were S.
Typhi followed by NTS and S. Paratyphi B, which agrees
with other studies conducted in India and Bangladesh
[21–23].
Among the DEC isolates, four strains were identified:
ETEC, EIEC, EAEC and EPEC, with EPEC being the
most predominant species. Four strains of DEC (ETEC,
EIAC, EAEC and EPEC) were the third most common
group of enteropathogens, accounting for 18.0% of all
isolates. The predominance of ETEC strain, among the
DEC, in agreement with previous studies carried out in
Bangladesh, Tunisia and Kenya [24–26]. ETEC was asso-
ciated with one third of diarrhoea cases identified in
children in the recent GEMS Study [4].
DEC isolates were mainly recovered from children
below the age of 24 months, which corroborates with
the findings of a Nigerian study that also indicated that
most of the DEC isolates were mostly recovered from
this age group [27]. In this study, EAEC was detected
from only 3 specimens, and EIEC and EPEC strains were
also detected but in low numbers.
Shigella species ranked third, with the most predomin-
ant species being S. flexneri, and affected mainly chil-
dren above 36 months of age. This finding was in
conformity with previous studies that have implicated S.
flexneri as the dominant species [28, 29]. However, other
studies have indicated that S. dysenteriae and S. boydii
to be more frequently isolated species [28–30].
Only three Campylobacter species were recovered
from the children, which might probably be due to the
fact that Campylobacter is as a fastidious organism
which requires special conditions for growth [31]. How-
ever, in a community-based study on the pathogen-
specific burden of diarrhoea in low-income countries,
Table 5 MDR patterns for Salmonella species [21]
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that involved eight study sites in South America, Africa and
Asia, Campylobacter exhibited the highest attributable bur-
den of diarrhoea amongst infants aged between 0 and
11 months [31].
In this study, all the organisms isolated exhibited high
level drug resistance, including resistance to multiple
drugs. V. cholerae isolates were totally resistant to cotri-
moxazole and nalidixic acid, partially resistant to
erythromycin, ciprofloxacin and norfloxacin. A previous
study in Zambia, during the 1990–1991 major cholera
outbreak, showed resistant to cotrimoxazole (97%),
tetracycline (95%), chloramphenicol (98%) and doxycyc-
line (70%) [19]. A similar study in Mozambique, found
that the V. cholerae O1 Ogawa isolates were resistant to
cotrimoxazole (100%), ampicillin (100%), nalidixic acid
[9], chloramphenicol (97%), nitrofurantoin (95%), tetra-
cycline (82%), azithromycin (56%) but sensitive to cipro-
floxacin (100%) (101).
For the Salmonella species, both S. Typhi and S. Para-
typhi B were totally resistant to ampicillin, cotrimoxa-
zole and streptomycin. In addition to the three drugs, S.
Typhi and S. Paratyphi B were also significantly resistant
to chloramphenicol and spectinomycin, respectively.
These findings are consistent with other studies in which
it was noted that there was an increase in the number of
Salmonella isolates being resistant to ampicillin, chlor-
amphenicol and cotrimoxazole [32].
A study on the Malawi-Mozambique border reported
findings similar to those in this study in which 100% of
S. Typhi were resistant to ampicillin, chloramphenicol
and cotrimoxazole [33]. Another study carried out in
Uganda showed that 76% of S. Typhi isolates were resist-
ant to ampicillin, streptomycin, sulfisoxazole, tetracyc-
line, and cotrimoxazole, but were susceptible to
chloramphenicol. This was in conformity with findings
from this study which also found that all the S. Typhi
isolates were susceptible to ceftaxime, gentamicin, and
spectinomycin [34].
This study also demonstrated the occurrence of MDR
strains of S. Typhi, S. Paratyphi B and the NTS which
were resistant to all traditional first line drugs tested:
ampicillin, chloramphenicol and cotrimoxazole. The com-
monest resistance pattern observed in this study was
ampicillin-chloramphenicol-cotrimoxazole-streptomycin
for S. Typhi, ampicillin-chloramphenicol-spectinomycin-
cotrimoxazole- streptomycin for S. Paratyphi B, while
NTS has 6 different patterns, which also included the
ampicillin-chloramphenicol-spectinomycin-cotrimoxa-
zole- streptomycin pattern. A similar study by Demczuk
and colleagues [35], revealed 26 resistance patterns with
the commonest patterns being nalidixic acid-resistant
(NAR) and ampicillin-chloramphenicol-nalidixic acid-
streptomycin-sulfisoxazole-cotrimoxazole in S. Typhi
compared to this to this study. This study indicated that
most of the Salmonella isolates were resistant to two or
more antibiotics and there was variability in the resistant
patterns of NTS. The MDR detection rates S. Typhi, S.
Paratyphi B, and the NTS were all 100%. Similar findings
of MDR strains (100%) were reported in Turkey [36].
All the DEC isolates were highly resistant to cotrimoxa-
zole, ampicillin, cefotaxime, ceftazidime, cefpodoxime,
nalidixic acid, and tetracycline. Generally, the isolates
showed moderate to high resistance to most drugs, and
low resistance to streptomycin and chloramphenicol. Our
data suggests the presence of MDR in all the DEC isolates
(100%) recovered in this study. This high prevalence of
MDR strains observed in this and other studies is worri-
some in that it limits treatment options for the patients.
Another important observation in this study with the
DEC isolates was that they were all resistant to third
generation cephalosporins used. Interesting, all the
isolates proved to be ESBL-producers. The detection
of ESBL-producing DEC isolates warrants attention in
the context of increasing resistance amongst the
enteropathogens. The high prevalence of ESBL in this
study may suggest over prescription of third gener-
ation cephalosporins in or inappropriate use of antibi-
otics in Lusaka.
In this study all the Shigella species were mainly resist-
ant to ampicillin, cotrimoxazole, chloramphenicol and
streptomycin, although S. boydii was sensitive to strepto-
mycin. The common resistance pattern was ampicillin-
chloramphenicol-cotrimoxazole-streptomycin. These
data suggest the presence of MDR in all the Shigella iso-
lates (100%) recovered. This MDR pattern was in con-
sonance with our study.
The two Campylobacter species isolated in this study
were resistant to co-trimoxazole and moderately resistant to
both ampicillin and tetracycline. In a Zimbabwean study,
50% of the isolates from humans and 82% from chickens
were resistant to co-trimoxazole, while for ampicillin and
tetracycline the levels were similar as those in this study.
Table 7 Antimicrobial resistance pattern of Salmonella species
Antimicrobial resistance pattern S. flexneri (6) S. dysenteriae (4) S. boydii (2)
AMP-AMC-CHL-CMX-STR 1(16.7)
AMP-CHL-CMX-STR-TET 1(16.7) 1(25) 2(100)
AMP-CHL-CMX-STR 3(50) 1(75)
AMP-CHL-CMX 1(16.7)
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However, MDR resistant isolates were consistently suscep-
tible to erythromycin, chloramphenicol and gentamicin [37].
Conclusion
This study isolated and identified five enteric bacteria
from stools obtained from children with diarrhea and
the majority of these organisms exhibited drug resistance
to ampicillin and co-trimoxazole. This presents very
limited treatment options for patients, necessitating a
review of empirical treatment practices at the UTH to
avoid further complications in affected patients. The
study however, recommend good hygienic practices in
different communities through public health educational
programme in order to avoid cases diarrhoea infections
among children.
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